Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-obesity Prescription industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Zealand Pharma
Zydus Cadila
Bridge BioResearch
Compellis Pharmaceuticals
Arena Pharmaceuticals
Arrowhead Research
Yungjin Pharm
Alpex Pharma
By Type:
Orlistat
Phentermine and Topiramate
Liraglutide
Lorcaserin
Bupropion and Naltrexone
By Application:
Retail Pharmacies
Hospital Pharmacies
E-Commerce
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anti-obesity Prescription Market Overview 2018-2029
-
1.1 China Anti-obesity Prescription Industry Development Overview
-
1.2 China Anti-obesity Prescription Industry Development History
-
1.3 China Anti-obesity Prescription Industry Market Size (2018-2029)
-
1.4 China Anti-obesity Prescription Market Analysis by Type from Production Side
-
1.4.1 China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Orlistat (2018-2029)
-
1.4.2 China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Phentermine and Topiramate (2018-2029)
-
1.4.3 China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)
-
1.4.4 China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Lorcaserin (2018-2029)
-
1.4.5 China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Bupropion and Naltrexone (2018-2029)
-
1.5 China Anti-obesity Prescription Market Analysis by Application from Consumption End
-
1.5.1 China Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.2 China Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.3 China Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate of E-Commerce (2018-2029)
-
1.6 China Anti-obesity Prescription Market Analysis by Region
-
1.6.1 North China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
Chapter 2 China Anti-obesity Prescription Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anti-obesity Prescription Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anti-obesity Prescription Market Status and Competition Analysis in 2023
-
2.2.3 China Anti-obesity Prescription Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anti-obesity Prescription Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anti-obesity Prescription Industry Development
Chapter 3 Anti-obesity PrescriptionIndustry Chain Analysis
-
3.1 Anti-obesity Prescription Industry Chain
-
3.2 Anti-obesity Prescription Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anti-obesity Prescription Market
-
3.3 Anti-obesity Prescription Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anti-obesity Prescription Market
Chapter 4 China Anti-obesity Prescription Market, by Type
-
4.1 China Anti-obesity Prescription Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anti-obesity Prescription Total Production Volume and Growth Rate from Production Side
-
4.5 China Anti-obesity Prescription Production Volume and Growth Rate, by Type
-
4.5.1 China Anti-obesity Prescription Production Volume and Growth Rate of Orlistat
-
4.5.2 China Anti-obesity Prescription Production Volume and Growth Rate of Phentermine and Topiramate
-
4.5.3 China Anti-obesity Prescription Production Volume and Growth Rate of Liraglutide
-
4.5.4 China Anti-obesity Prescription Production Volume and Growth Rate of Lorcaserin
-
4.5.5 China Anti-obesity Prescription Production Volume and Growth Rate of Bupropion and Naltrexone
Chapter 5 China Anti-obesity Prescription Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anti-obesity Prescription Total Market Size and Growth Rate from Consumption End
-
5.5 China Anti-obesity Prescription Market Size and Growth Rate, by Application
-
5.5.1 China Anti-obesity Prescription Market Size and Growth Rate of Retail Pharmacies
-
5.5.2 China Anti-obesity Prescription Market Size and Growth Rate of Hospital Pharmacies
-
5.5.3 China Anti-obesity Prescription Market Size and Growth Rate of E-Commerce
Chapter 6 China Anti-obesity Prescription Market, by Region
-
6.1 China Anti-obesity Prescription Production Volume and Production Value, by Region
-
6.2 China Anti-obesity Prescription Sales Volume and Sales Value, by Region
Chapter 7 North China Anti-obesity Prescription Market Analysis
-
7.1 North China Anti-obesity Prescription Market, by Type
-
7.2 North China Anti-obesity Prescription Market, by Application
Chapter 8 Central China Anti-obesity Prescription Market Analysis
-
8.1 Central China Anti-obesity Prescription Market, by Type
-
8.2 Central China Anti-obesity Prescription Market, by Application
Chapter 9 South China Anti-obesity Prescription Market Analysis
-
9.1 South China Anti-obesity Prescription Market, by Type
-
9.2 South China Anti-obesity Prescription Market, by Application
Chapter 10 East China Anti-obesity Prescription Market Analysis
-
10.1 East China Anti-obesity Prescription Market, by Type
-
10.2 East China Anti-obesity Prescription Market, by Application
Chapter 11 Northeast China Anti-obesity Prescription Market Analysis
-
11.1 Northeast China Anti-obesity Prescription Market, by Type
-
11.2 Northeast China Anti-obesity Prescription Market, by Application
Chapter 12 Southwest China Anti-obesity Prescription Market Analysis
-
12.1 Southwest China Anti-obesity Prescription Market, by Type
-
12.2 Southwest China Anti-obesity Prescription Market, by Application
Chapter 13 Northwest China Anti-obesity Prescription Market Analysis
-
13.1 Northwest China Anti-obesity Prescription Market, by Type
-
13.2 Northwest China Anti-obesity Prescription Market, by Application
Chapter 14 Company Profiles
-
14.1 Zealand Pharma
-
14.1.1 Zealand Pharma Company Profile
-
14.1.2 Zealand Pharma Anti-obesity Prescription Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Zydus Cadila
-
14.2.1 Zydus Cadila Company Profile
-
14.2.2 Zydus Cadila Anti-obesity Prescription Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Bridge BioResearch
-
14.3.1 Bridge BioResearch Company Profile
-
14.3.2 Bridge BioResearch Anti-obesity Prescription Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Compellis Pharmaceuticals
-
14.4.1 Compellis Pharmaceuticals Company Profile
-
14.4.2 Compellis Pharmaceuticals Anti-obesity Prescription Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Arena Pharmaceuticals
-
14.5.1 Arena Pharmaceuticals Company Profile
-
14.5.2 Arena Pharmaceuticals Anti-obesity Prescription Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Arrowhead Research
-
14.6.1 Arrowhead Research Company Profile
-
14.6.2 Arrowhead Research Anti-obesity Prescription Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Yungjin Pharm
-
14.7.1 Yungjin Pharm Company Profile
-
14.7.2 Yungjin Pharm Anti-obesity Prescription Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Alpex Pharma
-
14.8.1 Alpex Pharma Company Profile
-
14.8.2 Alpex Pharma Anti-obesity Prescription Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anti-obesity Prescription Industry Research Conclusions
-
15.2 Anti-obesity Prescription Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anti-obesity Prescription Industry Market Size (2018-2029)
-
Figure China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Orlistat (2018-2029)
-
Figure China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Phentermine and Topiramate (2018-2029)
-
Figure China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)
-
Figure China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Lorcaserin (2018-2029)
-
Figure China Anti-obesity Prescription Production Volume, Production Value and Growth Rate of Bupropion and Naltrexone (2018-2029)
-
Figure China Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate of E-Commerce (2018-2029)
-
Figure North China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
Figure Central China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
Figure South China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
Figure East China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anti-obesity Prescription Market Size and Growth Rate from 2018-2029
-
Figure Anti-obesity Prescription Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anti-obesity Prescription Market Share by Type in 2018
-
Figure China Anti-obesity Prescription Market Share by Type in 2023
-
Figure China Anti-obesity Prescription Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anti-obesity Prescription Production Volume and Growth Rate of Orlistat (2018-2023)
-
Figure China Anti-obesity Prescription Production Volume and Growth Rate of Phentermine and Topiramate (2018-2023)
-
Figure China Anti-obesity Prescription Production Volume and Growth Rate of Liraglutide (2018-2023)
-
Figure China Anti-obesity Prescription Production Volume and Growth Rate of Lorcaserin (2018-2023)
-
Figure China Anti-obesity Prescription Production Volume and Growth Rate of Bupropion and Naltrexone (2018-2023)
-
Figure China Anti-obesity Prescription Market Share by Application in 2018
-
Figure China Anti-obesity Prescription Market Share by Application in 2023
-
Figure China Anti-obesity Prescription Total Market Size and Growth Rate from Consumption End
-
Figure China Anti-obesity Prescription Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Anti-obesity Prescription Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Anti-obesity Prescription Market Size and Growth Rate of E-Commerce (2018-2023)
-
Table China Anti-obesity Prescription Production Volume by Region (2018-2023)
-
Table China Anti-obesity Prescription Production Volume Share by Region (2018-2023)
-
Figure China Anti-obesity Prescription Production Volume Share by Region (2018-2023)
-
Table China Anti-obesity Prescription Production Value by Region (2018-2023)
-
Table China Anti-obesity Prescription Production Value Share by Region (2018-2023)
-
Figure China Anti-obesity Prescription Production Value Share by Region (2018-2023)
-
Table China Anti-obesity Prescription Sales Volume by Region (2018-2023)
-
Table China Anti-obesity Prescription Sales Volume Share by Region (2018-2023)
-
Figure China Anti-obesity Prescription Sales Volume Share by Region (2018-2023)
-
Table China Anti-obesity Prescription Sales Value by Region (2018-2023)
-
Table China Anti-obesity Prescription Sales Value Share by Region (2018-2023)
-
Figure China Anti-obesity Prescription Sales Value Share by Region (2018-2023)
-
Table North China Anti-obesity Prescription Production Volume by Type (2018-2023)
-
Table North China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Figure North China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Table North China Anti-obesity Prescription Sales Volume by Application (2018-2023)
-
Table North China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Figure North China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Table Central China Anti-obesity Prescription Production Volume by Type (2018-2023)
-
Table Central China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Figure Central China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Table Central China Anti-obesity Prescription Sales Volume by Application (2018-2023)
-
Table Central China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Figure Central China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Table South China Anti-obesity Prescription Production Volume by Type (2018-2023)
-
Table South China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Figure South China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Table South China Anti-obesity Prescription Sales Volume by Application (2018-2023)
-
Table South China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Figure South China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Table East China Anti-obesity Prescription Production Volume by Type (2018-2023)
-
Table East China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Figure East China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Table East China Anti-obesity Prescription Sales Volume by Application (2018-2023)
-
Table East China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Figure East China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anti-obesity Prescription Production Volume by Type (2018-2023)
-
Table Northeast China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Table Northeast China Anti-obesity Prescription Sales Volume by Application (2018-2023)
-
Table Northeast China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anti-obesity Prescription Production Volume by Type (2018-2023)
-
Table Southwest China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Table Southwest China Anti-obesity Prescription Sales Volume by Application (2018-2023)
-
Table Southwest China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anti-obesity Prescription Production Volume by Type (2018-2023)
-
Table Northwest China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anti-obesity Prescription Production Volume Share by Type (2018-2023)
-
Table Northwest China Anti-obesity Prescription Sales Volume by Application (2018-2023)
-
Table Northwest China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anti-obesity Prescription Sales Volume Share by Application (2018-2023)
-
Table Zealand Pharma Company Profile
-
Table Zealand Pharma Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
Table Zydus Cadila Company Profile
-
Table Zydus Cadila Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
Table Bridge BioResearch Company Profile
-
Table Bridge BioResearch Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
Table Compellis Pharmaceuticals Company Profile
-
Table Compellis Pharmaceuticals Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
Table Arena Pharmaceuticals Company Profile
-
Table Arena Pharmaceuticals Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
Table Arrowhead Research Company Profile
-
Table Arrowhead Research Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
Table Yungjin Pharm Company Profile
-
Table Yungjin Pharm Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
Table Alpex Pharma Company Profile
-
Table Alpex Pharma Anti-obesity Prescription Revenue, Price and Gross (2018-2023)
-
